299
Participants
Start Date
March 8, 2019
Primary Completion Date
February 18, 2022
Study Completion Date
October 31, 2025
troriluzole
Administered orally
Placebo
Administered orally
Columbia University, New York
University of Pennsylvania, Philadelphia
Johns Hopkins Medicine, Lutherville
Duke University Movement Disorders Clinic, Durham
Emory, Atlanta
Mayo Clinic Florida, Jacksonville
University of Florida Health, Gainesville
University of South Florida, Tampa
University of Michigan, Ann Arbor
Northwest Neurology, Ltd., Rolling Meadows
Northwestern University, Chicago
University of Chicago, Chicago
Houston Methodist, Houston
University of Colorado Hospital, Aurora
Barrow Neurological Institute, Phoenix
UCLA, Los Angeles
CNS Trials, Long Beach
UCSF, San Francisco
Swedish Health Services, Seattle
Central South University Xiangya Hospital, Changsha
West China Hospital of Sichuan University, Chengdu
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Lead Sponsor
Biohaven Pharmaceuticals, Inc.
INDUSTRY